Mena Mansour, MD
Associate Professor, Pathology & Immunology
Section Head, Intraoperative Consultation
- Phone: 314-273-2744
- Email: mmansour@nospam.wustl.edu
Division
- Anatomic & Molecular Pathology
Education
- Bachelor of Medicine and Surgery (MBBCh): University of Alexandria Faculty of Medicine, Alexandria, Egypt (2005)
- Residency, Anatomical and Clinical Pathology : Icahn School of Medicine at Mount Sinai, New York, New York (2016)
- Fellowship, Clinical, Endocrine, Head and Neck: Yale-New Haven Hospital, New Haven, CT (2017)
- Residency, Anatomical and Clinical Pathology : Icahn School of Medicine at Mount Sinai, New York, New York (2018)
Board Certifications
- Diplomate of the American Board of Pathology (Anatomic and clinical pathology, 2028)
- Missouri Medical License (active)
- Pennsylvania Medical License (active)
Recognition
- Chief Resident, Department of Pathology, Icahn School of Medicine at Mount Sinai, New York, New York, 2015-2016
Clinical Interests
- Head and neck squamous cell carcinoma
- HPV related head and neck diseases
- Thyroid and adrenal pathology
- Gastrointestinal pathology
Research Interests
I am interested in studying HPV related tumors of the head and neck with focus on diagnostic and prognostic markers for these tumors.
Selected Publications
Irene Ramos, Mena Mansour, Teddy John Wohlbold, Megan E. Ermler, Ariana Hirsh, Jonathan A. Runstadler, Ana Fernandez-Sesma, and Florian Krammer. The hemagglutinin of emerging H10N8 influenza viruses shows binding to upper respiratory tract human receptors while maintaining a preference for avian-like glycans Emerging Infectious Diseases 2015 Jul http://dx.doi.org/10.3201/eid2107 |
Sara Cuadrado-Castano, Juan Ayllon, Mena Mansour, Janis de la Iglesia-Vicente, Stefan Jordan, Shashank Tripathi, Adolfo García-Sastre, and Enrique Villar Enhancement of the pro-apoptotic properties of Newcastle disease virus promotes tumor remission in syngeneic murine cancer models Mol Cancer Ther. 2015 May;14(5):1247-58. doi: 10.1158/1535-7163.MCT-14-0913. Epub 2015 Mar 11 |
Dmitriy Zamarin, Rikke B. Holmgaard, Sumit K. Subudhi, Joon Seok Park, Mena Mansour, Peter Palese, Taha Merghoub, Jedd D. Wolchok, and James P. Allison Localized oncolytic virotherapy overcomes systemic tumor resistance to immunotherapy with immune checkpoint blockade. Sci Transl Med. 2014 Mar 5;6(226):226ra32 |
Mena Mansour, Peter Palese, and Dmitriy Zamarin Oncolytic specificity of Newcastle Disease Virus is mediated by selectivity for apoptosis-resistant cells J. Virol. published ahead of print on 6 April 2011, doi:10.1128/JVI.01537-10 |
Zamarin D, Martínez-Sobrido L, Kelly K, Mansour M, Sheng G, Vigil A, GarcíaSastre A, Palese P, Fong Y. Enhancement of Oncolytic Properties of Recombinant Newcastle Disease Virus Through Antagonism of Cellular Innate Immune Responses. Molecular Therapy. 2009 Feb; 17(4): 697-706. PMID: 19209145 |
Cheng GZ, Zhang W, Sun M, Wang Q, Coppola D, Mansour M, Xu L, Costanzo C, Cheng JQ, Wang LH. Twist is transcriptionally induced by activation of STAT3 and mediates STAT3 oncogenic function. J Biol Chem. 2008 Mar; 283(21): 14665-73. Cited in PubMed; PMID: 18353781 |
Presentations & Posters
A Maxillary Expansile Soft Tissue Lesion, Poster presented at the annual CAP meeting, Washington DC, 10/2017 |
Keep Your Eye on the Ball, Walsh presentation at the annual North American Neuro-ophthalmology Society (NANOS), Washington DC, 04/2017 |
Incidence of Recently Described Salivary Gland Carcinoma Types Presenting in an Urban Population: A Retrospective Analysis, Poster presented at the annual United States & Canadian Academy of Pathology meeting, Seattle, WA, 03/2016 |
Prognostic Significance of Venous-Associated Colorectal Cancer Tumor Deposits Identified by Elastic Tissue Staining |
Assistant
Keli Morris
314-362-1329
kelibeckett@wustl.edu
BJCIH Room 3422